Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Del Frate

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Rheumatology (Oxford, England)|February 20, 2021
Timing of rituximab and immunoglobulin level influence the risk of death for COVID-19 in ANCA-associated vasculitisLuca Quartuccio, Elena Treppo, Marco Binutti, et al.
Frontiers in Immunology|March 13, 2023
Unmet needs in ANCA-associated vasculitis: Physicians' and patients' perspectivesLuca Quartuccio, Elena Treppo, Livio Urso, et al.
Therapeutic Advances in Musculoskeletal Disease|October 7, 2021
Diagnosis and management of lung involvement in systemic lupus erythematosus and Sjögren's syndrome: a literature reviewRoberto Depascale, Giulia Del Frate, Michela Gasparotto, et al.
Viruses|July 27, 2022
Safety of Biologic-DMARDs in Rheumatic Musculoskeletal Disorders: A Population-Based Study over the First Two Waves of COVID-19 OutbreakArianna Sonaglia, Rosanna Comoretto, Enrico Pasut, et al.
Clinical and Experimental Rheumatology|May 6, 2022
Systemic vasculitis: one year in review 2022Gaetano La Rocca, Giulia Del Frate, Paolo Delvino, et al.
Clinical and Experimental Rheumatology|April 19, 2023
Systemic vasculitis: one year in review 2023Michele Moretti, Elena Treppo, Sara Monti, et al.
Clinical Rheumatology|October 20, 2022
Correction to: Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC)Luca Quartuccio, Alessandra Bortoluzzi, Carlo Alberto Scirè, et al.
Clinical Rheumatology|September 28, 2022
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC)Luca Quartuccio, Alessandra Bortoluzzi, Carlo Alberto Scirè, et al.
Journal of Clinical Immunology|February 16, 2023
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and ImmunogenicityLaura Gragnani, Marcella Visentini, Serena Lorini, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Rheumatology (Oxford, England)|February 20, 2021
Timing of rituximab and immunoglobulin level influence the risk of death for COVID-19 in ANCA-associated vasculitisLuca Quartuccio, Elena Treppo, Marco Binutti, et al.
Frontiers in Immunology|March 13, 2023
Unmet needs in ANCA-associated vasculitis: Physicians' and patients' perspectivesLuca Quartuccio, Elena Treppo, Livio Urso, et al.
Therapeutic Advances in Musculoskeletal Disease|October 7, 2021
Diagnosis and management of lung involvement in systemic lupus erythematosus and Sjögren's syndrome: a literature reviewRoberto Depascale, Giulia Del Frate, Michela Gasparotto, et al.
Viruses|July 27, 2022
Safety of Biologic-DMARDs in Rheumatic Musculoskeletal Disorders: A Population-Based Study over the First Two Waves of COVID-19 OutbreakArianna Sonaglia, Rosanna Comoretto, Enrico Pasut, et al.
Clinical and Experimental Rheumatology|May 6, 2022
Systemic vasculitis: one year in review 2022Gaetano La Rocca, Giulia Del Frate, Paolo Delvino, et al.
Clinical and Experimental Rheumatology|April 19, 2023
Systemic vasculitis: one year in review 2023Michele Moretti, Elena Treppo, Sara Monti, et al.
Clinical Rheumatology|October 20, 2022
Correction to: Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC)Luca Quartuccio, Alessandra Bortoluzzi, Carlo Alberto Scirè, et al.
Clinical Rheumatology|September 28, 2022
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC)Luca Quartuccio, Alessandra Bortoluzzi, Carlo Alberto Scirè, et al.
Journal of Clinical Immunology|February 16, 2023
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and ImmunogenicityLaura Gragnani, Marcella Visentini, Serena Lorini, et al.
Pageof 1